| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tara Kervin, Mathula Thangaraj. The Relationship Between Bone Mineral Density and Cardiovascular Function in Duchenne Muscular Dystrophy: A Retrospective Cohort Study. PLoS currents. vol 10. 2020-09-29. PMID:29623244. |
duchenne muscular dystrophy (dmd) is an x-linked genetic disorder that causes progressive skeletal and cardiac muscle weakness in boys. |
2020-09-29 |
2023-08-13 |
Not clear |
| David P Burns, Sarah E Drummond, Dearbhla Bolger, Amélie Coiscaud, Kevin H Murphy, Deirdre Edge, Ken D O'Hallora. N-acetylcysteine Decreases Fibrosis and Increases Force-Generating Capacity of Antioxidants (Basel, Switzerland). vol 8. issue 12. 2020-09-28. PMID:31771272. |
n-acetylcysteine decreases fibrosis and increases force-generating capacity of respiratory muscle weakness occurs due to dystrophin deficiency in duchenne muscular dystrophy (dmd). |
2020-09-28 |
2023-08-13 |
Not clear |
| Jia-Min Li, Han Che. Recurrent hypotension induced by sacubitril/valsartan in cardiomyopathy secondary to Duchenne muscular dystrophy: A case report. World journal of clinical cases. vol 7. issue 23. 2020-09-28. PMID:31832414. |
skeletal muscle weakness progressively develops in dmd patients and usually leads to respiratory failure in the early adolescent years. |
2020-09-28 |
2023-08-13 |
Not clear |
| Thiago Henrique da Silva, Isabela Pessa Anequini, Francis Meire Fávero, Mariana Callil Voos, Acary Souza Bulle Oliveira, Juliana Aparecida Rhein Telles, Fátima Aparecida Caroman. Functional performance and muscular strength in symptomatic female carriers of Duchenne muscular dystrophy. Arquivos de neuro-psiquiatria. vol 78. issue 3. 2020-08-10. PMID:32022138. |
approximately 8% of female dmd carriers have muscle weakness and cardiomyopathy. |
2020-08-10 |
2023-08-13 |
Not clear |
| David P Burns, Kevin H Murphy, Eric F Lucking, Ken D O'Hallora. Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness. The Journal of physiology. vol 597. issue 3. 2020-05-13. PMID:30570134. |
respiratory muscle weakness is a major feature of duchenne muscular dystrophy (dmd), yet little is known about the neural control of the respiratory muscles in dmd and animal models of dystrophic disease. |
2020-05-13 |
2023-08-13 |
mouse |
| Angus Lindsay, Alexie A Larson, Mayank Verma, James M Ervasti, Dawn A Low. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle. Journal of applied physiology (Bethesda, Md. : 1985). vol 126. issue 2. 2020-04-27. PMID:30571283. |
mutation to the dystrophin gene causes skeletal muscle weakness in patients with duchenne muscular dystrophy (dmd) or becker muscular dystrophy (bmd). |
2020-04-27 |
2023-08-13 |
mouse |
| F Camela, M Gallucci, G Ricc. Cough and airway clearance in Duchenne muscular dystrophy. Paediatric respiratory reviews. vol 31. 2020-02-26. PMID:30553655. |
people with duchenne muscular dystrophy (dmd), develop a respiratory muscle weakness that results in weakened cough, airway clearance impairment and over time respiratory failure and death. |
2020-02-26 |
2023-08-13 |
Not clear |
| Jingjing Zhang, Dingyuan Ma, Gang Liu, Yuguo Wang, An Liu, Li Li, Chunyu Luo, Ping Hu, Zhengfeng X. Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center. BMC medical genetics. vol 20. issue 1. 2020-02-14. PMID:31727011. |
patients with dmd usually have severe and fatal symptoms, including progressive irreversible muscle weakness and atrophy complicated with gastrocnemius muscle pseudohypertrophy. |
2020-02-14 |
2023-08-13 |
Not clear |
| L H C Peeters, I Kingma, J H van Dieën, I J M de Groo. Don't forget the trunk in Duchenne muscular dystrophy patients: more muscle weakness and compensation than expected. Journal of neuroengineering and rehabilitation. vol 16. issue 1. 2020-02-11. PMID:30917845. |
performing daily activities independently becomes more difficult in time for patients with duchenne muscular dystrophy (dmd) due to muscle weakness. |
2020-02-11 |
2023-08-13 |
Not clear |
| Shanshan Gao, Aiping Lu, Sarah Amra, Ping Guo, Johnny Huar. TIPE2 gene transfer with adeno-associated virus 9 ameliorates dystrophic pathology in mdx mice. Human molecular genetics. vol 28. issue 10. 2020-02-07. PMID:30608588. |
taken together, our results indicate that a reduction of tipe2 expression is observed in dystrophic skeletal muscle, when compared to wt and more importantly that tipe2 gene delivery may provide as a novel anti-inflammatory therapy to alleviate the muscle weakness in dmd patients. |
2020-02-07 |
2023-08-13 |
mouse |
| Claudia R Senesac, Donovan J Lott, Rebecca J Willcocks, Tina Duong, Barbara K Smit. Lower Extremity Functional Outcome Measures in Duchenne Muscular Dystrophy-A Delphi Survey. Journal of neuromuscular diseases. vol 6. issue 1. 2020-01-02. PMID:30562905. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease characterized by progressive muscle weakness, multiple system involvement and premature mortality. |
2020-01-02 |
2023-08-13 |
Not clear |
| Johnny Huar. Stem cells, blood vessels, and angiogenesis as major determinants for musculoskeletal tissue repair. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. vol 37. issue 6. 2019-12-20. PMID:29786150. |
dmd is a devastating inherited x-linked muscle disease characterized by progressive muscle weakness due to lack of dystrophin expression in muscle fiber sarcolemma. |
2019-12-20 |
2023-08-13 |
Not clear |
| Maricela Rodríguez-Cruz, Oriana Del Rocío Cruz-Guzmán, Tomás Almeida-Becerril, Alan Donovan Solís-Serna, Salvador Atilano-Miguel, Juan Raúl Sánchez-González, Lourdes Barbosa-Cortés, Eugenia Dolores Ruíz-Cruz, Juan Carlos Huicochea, Alan Cárdenas-Conejo, Rosa Elena Escobar-Cedillo, Carlos Alberto Yam-Ontiveros, Edgar F Ricárdez-Marcia. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial. Clinical nutrition (Edinburgh, Scotland). vol 37. issue 6 Pt A. 2019-12-02. PMID:28987470. |
dmd is a neuromuscular disease and its clinical course comprises chronic inflammation and gradual muscle weakness. |
2019-12-02 |
2023-08-13 |
Not clear |
| Patricia Piñol-Jurado, Xavier Suárez-Calvet, Esther Fernández-Simón, Eduard Gallardo, Natalia de la Oliva, Anna Martínez-Muriana, Pedro Gómez-Gálvez, Luis M Escudero, María Pérez-Peiró, Lutz Wollin, Noemi de Luna, Xavier Navarro, Isabel Illa, Jordi Díaz-Maner. Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy. Cell death & disease. vol 9. issue 7. 2019-11-25. PMID:29991677. |
duchenne muscle dystrophy (dmd) is a genetic disorder characterized by progressive skeletal muscle weakness. |
2019-11-25 |
2023-08-13 |
mouse |
| Kristin N Heller, Joshua T Mendell, Jerry R Mendell, Louise R Rodino-Klapa. MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin. JCI insight. vol 2. issue 9. 2019-11-20. PMID:28469083. |
duchenne muscular dystrophy (dmd) is caused by dystrophin deficiency resulting in progressive muscle weakness and fibrotic scarring. |
2019-11-20 |
2023-08-13 |
mouse |
| Megan A Waldrop, Felecia Gumienny, Saleh El Husayni, Diane E Frank, Robert B Weiss, Kevin M Flaniga. Low-level dystrophin expression attenuating the dystrophinopathy phenotype. Neuromuscular disorders : NMD. vol 28. issue 2. 2019-11-14. PMID:29305136. |
this case suggests that very low levels of dmd exon skipping and dystrophin protein expression may result in amelioration of skeletal muscle weakness, a finding relevant to current dystrophin-restoring therapies. |
2019-11-14 |
2023-08-13 |
Not clear |
| Jana Strakova, Forum Kamdar, Debra Kulhanek, Maria Razzoli, Daniel J Garry, James M Ervasti, Alessandro Bartolomucci, DeWayne Townsen. Integrative effects of dystrophin loss on metabolic function of the mdx mouse. Scientific reports. vol 8. issue 1. 2019-10-28. PMID:30206270. |
duchenne muscular dystrophy (dmd) is a disease marked by the development of skeletal muscle weakness and wasting. |
2019-10-28 |
2023-08-13 |
mouse |
| Lisa C Power, Gina L O'Grady, Tim S Hornung, Craig Jefferies, Silmara Gusso, Paul L Hofma. Imaging the heart to detect cardiomyopathy in Duchenne muscular dystrophy: A review. Neuromuscular disorders : NMD. vol 28. issue 9. 2019-10-25. PMID:30119965. |
mutations in the dmd gene on the x-chromosome result in progressive skeletal muscle weakness as the main clinical manifestation. |
2019-10-25 |
2023-08-13 |
Not clear |
| Patrick Magrath, Nyasha Maforo, Pierangelo Renella, Stanley F Nelson, Nancy Halnon, Daniel B Enni. Cardiac MRI biomarkers for Duchenne muscular dystrophy. Biomarkers in medicine. vol 12. issue 11. 2019-09-05. PMID:30499689. |
duchenne muscular dystrophy (dmd) is a fatal inherited genetic disorder that results in progressive muscle weakness and ultimately loss of ambulation, respiratory failure and heart failure. |
2019-09-05 |
2023-08-13 |
Not clear |
| Viktoriia Kyrychenko, Sergii Kyrychenko, Malte Tiburcy, John M Shelton, Chengzu Long, Jay W Schneider, Wolfram-Hubertus Zimmermann, Rhonda Bassel-Duby, Eric N Olso. Functional correction of dystrophin actin binding domain mutations by genome editing. JCI insight. vol 2. issue 18. 2019-08-26. PMID:28931764. |
duchenne muscular dystrophy (dmd) is caused by mutations in the dystrophin gene (dmd) that result in progressive, debilitating muscle weakness, cardiomyopathy, and a shortened lifespan. |
2019-08-26 |
2023-08-13 |
human |